Hosted on MSN5d
Guggenheim Upgrades Surrozen (SRZN)
Fintel reports that on January 3, 2025, Guggenheim upgraded their outlook for Surrozen (NasdaqCM:SRZN) from Neutral to Buy.
Guggenheim upgrades Surrozen to Buy after ‘encouraging’ SZN-043 data
As previously reported, Guggenheim upgraded Surrozen (SRZN) to Buy from Neutral with a $45 price target Recent Phase 1b data for SZN-043, the ...
Surrozen upgraded to Buy from Neutral at Guggenheim
Guggenheim analyst Yatin Suneja upgraded Surrozen (SRZN) to Buy from Neutral with a $45 price target Don't Miss Our New Year's Offers:Discover ...
CNN3y
Surrozen Inc
Surrozen, Inc. is a clinical stage biotechnology company. It engages in the business of discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of ...
Block upgraded, Bumble downgraded: Wall Street's top analyst calls
Raymond James downgraded RingCentral (RNG) to Outperform from Strong Buy with a price target of $45, down from $50. The ...
Wall Street Journal27d
Surrozen Inc. Wt
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...